Eric Lander, President and Director of the Broad Institute1
NGS can be challenging – overcome the bottlenecks you face with the help of our single kit solution. We’ve combined the precision of our QIAseq DNA Panels with intuitive bioinformatics tools to create a single unified solution so you can detect low-frequency variants and analyze your NGS data with confidence. QIAseq DNA panels now include subscription licenses for CLC Genomics Workbench and QIAGEN Clinical Insight (QCI)-Interpret for QIAseq software, so you can make the leap from generating data to accumulating insights with greater ease and speed. Learn more here.
Myeloid Neoplasms
Lung Cancer
Actionable Solid Tumor
Comprehensive Cancer
Tumor Mutational Burden
Breast Cancer
Colorectal Cancer
BRCA1 and BRCA2
BRCA1 and BRCA2 Plus
Pharmacogenomics
Mitochondria
Inherited Disease
Learn more about QIAseq DNA Panels.
Create your own QIAseq DNA Custom Panels, which can be tailored to target exonic regions of genes, hotspots or SNPs, as well as intronic and promoter regions. Use the free, online QIAseq Targeted DNA Custom Panel Builder tool to select from RefSeq the genomic regions you wish to target, or upload your own custom target list. Access the tool and browse other valuable molecular solutions in the GeneGlobe Design and Analysis Hub.
Learn more about QIAseq DNA Custom Panels.
In addition to QIAseq custom panels, you can also create QIAseq Targeted DNA Extended Panels, which allow you to extend the content of any of the cataloged panels by adding up to 100 new primers.
Learn more about QIAseq Targeted DNA Extended Panels.
QIAseq DNA Panel kits don’t just deliver superior sequencing coverage and a faster workflow — they also provide the tools you need to gain knowledge from results, using QCI-Interpret for QIAseq software. Supporting more than 1000 laboratories and professionals worldwide, the cloud-based QCI platform provides all the capabilities required to transform complex NGS data into insights, in an easy-to-understand sample report.
• Discover novel findings more quickly
• Access comprehensive variant information
• Use tailored workflows for multiple applications
Check out an example report here.
Learn what our customers are saying about our QIAseq DNA panels and our bioinformatics solutions for analysis and interpretation of NGS data.
"For researchers to be able to analyze very large numbers of samples at the same time, we needed a strategy which was high-throughput and cost-effective. We are running 800 samples a week in batch mode and analyzing them across 38 genes, all with the help of the QIAseq panels."
– Dr. Fergus Couch, Mayo Clinic
Watch the full movie here.
* Required field
By clicking submit you agree that QIAGEN may use your personal information for the purpose of shipping the kits and for internal business and marketing purposes. The information will not be sold to any third party. QIAGEN may transfer your personal information to our CRM system (hosted by SalesForce.com, Inc. and Oracle Corp.) solely for the purposes of data hosting and QIAGEN email distribution. You may unsubscribe at any time. Your data will be processed in compliance with applicable privacy laws including the EU General Data Protection Regulation all information you provide in this site will be governed by our Privacy Policy.
Want to see how our NGS and analysis tools could work in your own lab? Check out these webinars to discover how our experts seamlessly go from sequencing to insights.
Speaker: Jonathan M. Shaffer, M.B.A., Ph.D., Associate Director, NGS Assay Technologies – QIAGEN
Speaker: Prakriti Mudvari, Ph.D., Senior Bioinformatics Scientist – QIAGEN
1 Eric Lander, president and director of the Broad Institute (2015, June 24) Researchers to use Google cloud to aid in genome analysis. [Press release]. Retrieved from https://www.computerworld.com/article/2940374/researchers-to-use-google-cloud-to-aid-in-genome-analysis.html
The products mentioned here are intended for molecular biology applications. These products are not intended for the diagnosis, prevention, or treatment of a disease.
Thank you for your interest in QIAGEN’s targeted NGS panels and optimized analysis tools. You will be contacted shortly by one of our application scientists.
